Sandbox: manpreet kaur: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 58: | Line 58: | ||
| | | | ||
* PPI(standard dose) | * PPI(standard dose) | ||
* Rifabutin(300mg | * Rifabutin(300mg) | ||
* Amox(1gm) | |||
| | | | ||
| | | |
Revision as of 19:53, 27 October 2017
Salvage therapies for Helicobacter pylori infection | ||||
---|---|---|---|---|
Regimen | Drugs(doses) | Dosing frequency | Duration(days) | FDA approval |
Bismuth quadruple |
|
BID
QID QID TID or QID |
14 | NO(a) |
Levofloxacin triple |
|
BID
QD BID |
14 | NO |
Concomitant |
|
BID
BID BID BID or TID |
10-14 | NO |
Rifabutin triple |
|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
References
- References should be cited for the material that you have put on your page. Type in {{reflist|2}}.This will generate your references in small font, in two columns, with links to the original article and abstract.
- For information on how to add references into your page, click here.